HMGB1 and neoplasm: HMGB1 induces immunogenic cell death, activates DCs and T cells to trigger immune responses, and disrupts immune evasion mechanisms in tumor cells, thereby enhancing their susceptibility to recognition and attack by the immune system [137, 138, 139].